SEC Form 4 research
| Issuer | Unicycive Therapeutics, Inc. |
|---|---|
| Tickers | UNCY |
| Reporting owners | 10 |
| Officers and directors | 1 |
| Last public filing | 2026-10-29 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-29 | 2026-10-28 | Manning Meredith | A | 27,000 | $0 | Not reported |
| 2026-10-29 | 2026-10-28 | Manning Meredith | A | 3,350 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.